Skip to main content
. Author manuscript; available in PMC: 2009 Nov 16.
Published in final edited form as: J Urol. 2008 Dec 13;181(2):609–614. doi: 10.1016/j.juro.2008.10.035

Table 2.

European Society of Urologic Oncology (ESUO) classification with Prostate Specific Antigen (PSA), Biopsy Gleason grade and % Biopsy cores positive

ESUO classification
        Negative 665 (47%)
        Positive 741 (53%)
Criteria met for classification of ESUO positive
        Only Preoperative PSA >= 10ng/ml 66 (5%)
        Only Biopsy Gleason grade > 6 287 (20%)
        Only >50% Biopsy cores positive 133 (9%)
        Preoperative PSA >= 10ng/ml & Biopsy Gleason grade >6 54 (4%)
        Preoperative PSA >= 10ng/ml & >50% Biopsy Cores Positive 23 (2%)
        Biopsy Gleason grade >6 & >50% Biopsy Cores Positive 146 (10%)
        Preoperative PSA >=10ng/ml & Biopsy Gleason grade >6 & >50% Biopsy Cores Positive 32 (2%)